MicroTransponder Secures $65 Million for Vivistim Expansion
Deal News | Mar 12, 2025 | USVP Management Co LLC
MicroTransponder, a medical technology company focused on stroke recovery, has successfully secured $65 million in funding. This investment is spearheaded by USVP Management Co LLC, a prominent private equity firm. The funding will be directed towards the enhancement and broader adoption of MicroTransponder's Vivistim System, a device designed to aid chronic stroke patients in their recovery process. This strategic financial injection aims to expand the availability and efficacy of the Vivistim System, potentially transforming the standard of care for stroke rehabilitation.
Sectors
- Medical Technology
- Private Equity
Geography
- United States – Both MicroTransponder and USVP Management Co LLC are based in the United States, indicating that the funding and its subsequent impact are primarily focused in this region.
Industry
- Medical Technology – The article revolves around MicroTransponder, a company in the medical technology sector, focusing on devices for stroke recovery.
- Private Equity – USVP Management Co LLC, a private equity firm, is providing significant funding for the development and expansion of a medical technology.
Financials
- $65 million – The total funding amount secured by MicroTransponder to enhance the Vivistim System for chronic stroke recovery.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MicroTransponder | Target Company | Company | A medical technology company focused on developing innovative solutions for stroke recovery. |
| USVP Management Co LLC | Private Equity Firm | Company | A prominent private equity firm providing significant funding for MicroTransponder's growth and expansion. |